Concourse Financial Group Securities, Inc. Renovo Rx, Inc. Transaction History
Concourse Financial Group Securities, Inc.
- $0
- Q2 2025
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
100.0%
Previous 100.0%
Shares
17 transactions
Others Institutions Holding RNXT
# of Institutions
28Shares Held
8.86MCall Options Held
0Put Options Held
0-
Aigh Capital Management LLC Baltimore, MD2.62MShares$2.51 Million0.55% of portfolio
-
Awm Investment Company, Inc. New York, NY1.87MShares$1.8 Million0.35% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.61MShares$1.54 Million0.0% of portfolio
-
Bank Of The West975KShares$936,0000.27% of portfolio
-
Bleichroeder LP New York, NY500KShares$480,0000.21% of portfolio
About RenovoRx, Inc.
- Ticker RNXT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 9,066,860
- Market Cap $8.7M
- Description
- RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, In...